In-depth profiling identified shared mutations in TET2 and DNMT3A (DNA methyltransferase 3 alpha) genes in both B and T cell tumours which suggested a common clonal origin, although molecular signatures later discerned two distinct malignancies. This evidence concerns the gene DNMT3A and neoplasm.